Protect Hope for Huntington’s Disease Families
We need your voice. Recent reporting raises concerns that the FDA may be changing expectations at the end of gene therapy trials, including the trial for the Huntington's disease (HD) treatment AMT-130 being developed by uniQure. For patients and families who are...